AS601245
CAS No. 345987-15-7
AS601245( AS-601245 )
Catalog No. M14188 CAS No. 345987-15-7
A potent and selective inhibitor of JNK with IC50s of 70/220/150 nM for JNK1/2/3 respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 102 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 163 | In Stock |
|
| 25MG | 274 | In Stock |
|
| 50MG | 398 | In Stock |
|
| 100MG | 592 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAS601245
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective inhibitor of JNK with IC50s of 70/220/150 nM for JNK1/2/3 respectively.
-
DescriptionA potent and selective inhibitor of JNK with IC50s of 70/220/150 nM for JNK1/2/3 respectively; less potent for c-Src, c-Raf, p38a; exhibits in vitro and in vivo anti-inflammatory potential.(In Vitro):AS601245, an anti-Inflammatory JNK inhibitor, and Clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile in CaCo-2 colon cancer cells .(In Vivo):AS601245 (40, 60, and 80 mg/kg; i.p.) provides significant protection against the delayed loss of hippocampal CA1 neurons in a gerbil model of transient global ischemia.AS601245 (0.3-10 mg/kg; p.o.) is a potent inhibitor of LPS-induced TNF-α release in mice.
-
In Vitro——
-
In VivoAnimal Model:C3H/HEN mice Dosage:0.3, 1, 3, or 10 mg/kg Administration:P.o.Result:Decreased the TNF-α release in a dose-dependent manner.
-
SynonymsAS-601245
-
PathwayMAPK/ERK Signaling
-
TargetJNK
-
RecptorhJNK1| hJNK2| hJNK3
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number345987-15-7
-
Formula Weight372.4462
-
Molecular FormulaC20H16N6S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 35 mg/mL
-
SMILESN#C/C(C1=NC(NCCC2=CC=CN=C2)=NC=C1)=C3SC4=CC=CC=C4N\3
-
Chemical Name2-Benzothiazoleacetonitrile, -[2-[[2-(3-pyridinyl)ethyl]amino]-4-pyrimidinyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
d-Epigalbacin
d-Epigalbacin is a naturally occurring lignin. d-Epigalbacin is a potent, selective JNKs inhibitor, with IC50s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively.
-
Tanzisertib
Tanzisertib (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.Tanzisertib (CC-930) inhibits the formation of phospho-cJun in human PBMC stimulated by phorbol-12-myristate-13-acetate and phytohemeagglutinin (IC50=1 μM)[1] and it blocks the JNK pathway that is activated by pro-fibrotic cytokines in systemic sclerosis.
-
Caffeic Acid
Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.
Cart
sales@molnova.com